The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Do irinotecan (IRI) dose reductions driven by UGT1A1*28 genotyping prevent IRI-related severe neutropenia? A real-world study.
 
Nicola Personeni
Consulting or Advisory Role - Merck Serono
Speakers' Bureau - SERVIER
Travel, Accommodations, Expenses - Amgen; SERVIER
Other Relationship - Abbvie; Lilly
 
Rossana Mineri
No Relationships to Disclose
 
Angelica Michelini
No Relationships to Disclose
 
Silvia Bozzarelli
No Relationships to Disclose
 
Tiziana Pressiani
No Relationships to Disclose
 
Valeria Smiroldo
No Relationships to Disclose
 
Maria Teresa Sandri
No Relationships to Disclose
 
Laura Giordano
No Relationships to Disclose
 
Armando Santoro
Consulting or Advisory Role - ARQULE; Bayer; Bristol-Myers Squibb; Eisai; Gilead Sciences; MSD; Pfizer; Sanofi; SERVIER
Speakers' Bureau - Abbvie; Amgen; ArQule; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Eisai; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Sandoz; Servier; Takeda
 
Lorenza Rimassa
Honoraria - Abbvie; Amgen; AstraZeneca; Eisai; Gilead Sciences; Ipsen; Lilly; Roche; Sanofi
Consulting or Advisory Role - Amgen; ArQule; Basilea; Baxter; Bayer; Celgene; Eisai; Exelixis; Hengrui Therapeutics; Incyte; Ipsen; Italfarmaco; Lilly; Merck Sharp & Dohme; Roche; Sanofi; Sirtex Medical
Research Funding - Agios (Inst); ARMO BioSciences (Inst); ArQule (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Eisai (Inst); Exelixis (Inst); Exelixis/Ipsen (Inst); Incyte (Inst); Ipsen (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - ArQule; Ipsen